Obesity is associated with an increase in the fractional contribution of gluconeogenesis (GNG) to glucose production. We tested if this was related to the altered protein metabolism in obesity. GNG PEP (via phosphoenol pyruvate [PEP]) was measured after a 17-h fast using the deuterated water method and 2 H nuclear magnetic resonance spectroscopy of plasma glucose. Whole-body 13 C-leucine and 3 Hglucose kinetics were measured in the postabsorptive state and during a hyperinsulinemic-euglycemic-isoaminoacidemic clamp in 19 (10 men and 9 women) lean and 16 (7 men and 9 women) obese nondiabetic subjects. Endogenous glucose production was not different between groups. Postabsorptive %GNG PEP and GNG PEP flux were higher in obese subjects, and glycogenolysis contributed less to glucose production than in lean subjects. GNG PEP flux correlated with all indexes of adiposity and with postabsorptive leucine rate of appearance (R a ) (protein catabolism). GNG PEP was negatively related to the clamp glucose rate of disposal (R d ) and to the protein anabolic response to hyperinsulinemia. In conclusion, the increased contribution of GNG to glucose production in obesity is linked to increased postabsorptive protein catabolism and insulin resistance of both glucose and protein metabolism. Due to increased protein turnover rates, greater supply of gluconeogenic amino acids to the liver may trigger their preferential use over glycogen for glucose production. Diabetes 55:675-681, 2006 T he increased fractional contribution of gluconeogenesis (GNG) to postaborptive endogenous glucose production (EGP) in type 2 diabetes is well established (1), but its role in obesity is less clear. Elevated GNG has also been reported in obesity but is associated with a smaller contribution of glycogenolysis (GLY), and hence with no increase in EGP, and therefore euglycemia (2-4). Thus, since hepatic autoregulation (5) is apparently intact in obese subjects, it is not immediately clear what mechanism is responsible for increased GNG. Such autoregulation does not appear to be intact in type 2 diabetes (2,3,6), but it remains uncertain whether it causes increased EGP as hyperglycemia increases (1)(2)(3)7,8). Insulin resistance is a hallmark of both type 2 diabetes and obesity, affecting not only glucose and lipid metabolism (9) but protein as well. We have shown that whole-body protein catabolism is increased in hyperglycemic type 2 diabetic people but improves when normoglycemia is achieved with insulin and oral antihyperglycemic agents and with hypoenergetic feeding (10,11). Recently, we reported that postabsorptive rates of endogenous leucine rate of appearance (R a ) (index of protein catabolism) are increased in obese compared with lean women (12). Further, it is well known that when the portal vein glucagon/insulin relationship favors GNG, its rate can be controlled by the supply of substrate from the periphery (9,13). Taken together, these data led us to hypothesize that elevated protein catabolism in obesity contributes to higher GNG via incr...